CDK7 and cancer: It has been reported that THZ1, a specific inhibitor of CDK7 to block the phosphorylation of the CDK7 substrate RNAPII CTD by irreversible covalent binding to CDK7, can negatively affect gene expression, inhibiting the proliferation of cancer cells and the progression of animal xenograft models [19].